GSK Aims To Launch 13 Blockbusters In Five Years

Immuno-Oncology Central To Ambitions

 
• By Andrew McConaghie
GSK HQ
The consumer health division spin-out in 2022 will leave behind a leaner GSK focused on biopharma and vaccines.

More from Business

More from Scrip